PMID- 21778272 OWN - NLM STAT- MEDLINE DCOM- 20111201 LR - 20220309 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 52 IP - 10 DP - 2011 Sep 21 TI - Photoreceptor structure and function in patients with congenital achromatopsia. PG - 7298-308 LID - 10.1167/iovs.11-7762 [doi] AB - PURPOSE: To assess photoreceptor structure and function in patients with congenital achromatopsia. METHODS: Twelve patients were enrolled. All patients underwent a complete ocular examination, spectral-domain optical coherence tomography (SD-OCT), full-field electroretinographic (ERG), and color vision testing. Macular microperimetry (MP; in four patients) and adaptive optics (AO) imaging (in nine patients) were also performed. Blood was drawn for screening of disease-causing genetic mutations. RESULTS: Mean (+/- SD) age was 30.8 (+/- 16.6) years. Mean best-corrected visual acuity was 0.85 (+/- 0.14) logarithm of the minimal angle of resolution (logMAR) units. Seven patients (58.3%) showed either an absent foveal reflex or nonspecific retinal pigment epithelium mottling to mild hypopigmentary changes on fundus examination. Two patients showed an atrophic-appearing macular lesion. On anomaloscopy, only 5 patients matched over the entire range from 0 to 73. SD-OCT examination showed a disruption or loss of the macular inner/outer segments (IS/OS) junction of the photoreceptors in 10 patients (83.3%). Seven of these patients showed an optically empty space at the level of the photoreceptors in the fovea. AO images of the photoreceptor mosaic were highly variable but significantly disrupted from normal. On ERG testing, 10 patients (83.3%) showed evidence of residual cone responses to a single-flash stimulus response. The macular MP testing showed that the overall mean retinal sensitivity was significantly lower than normal (12.0 vs. 16.9 dB, P < 0.0001). CONCLUSIONS: The current approach of using high-resolution techniques to assess photoreceptor structure and function in patients with achromatopsia should be useful in guiding selection of patients for future therapeutic trials as well as monitoring therapeutic response in these trials. FAU - Genead, Mohamed A AU - Genead MA AD - Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, USA. FAU - Fishman, Gerald A AU - Fishman GA FAU - Rha, Jungtae AU - Rha J FAU - Dubis, Adam M AU - Dubis AM FAU - Bonci, Daniela Maria O AU - Bonci DM FAU - Dubra, Alfredo AU - Dubra A FAU - Stone, Edwin M AU - Stone EM FAU - Neitz, Maureen AU - Neitz M FAU - Carroll, Joseph AU - Carroll J LA - eng GR - R01 EY017607-05/EY/NEI NIH HHS/United States GR - P30EY001792/EY/NEI NIH HHS/United States GR - R01EY017607/EY/NEI NIH HHS/United States GR - C06 RR-RR016511/RR/NCRR NIH HHS/United States GR - R01 EY017607/EY/NEI NIH HHS/United States GR - T32EY014537/EY/NEI NIH HHS/United States GR - T32 EY014537/EY/NEI NIH HHS/United States GR - C06 RR016511/RR/NCRR NIH HHS/United States GR - P30 EY001931/EY/NEI NIH HHS/United States GR - P30 EY001792/EY/NEI NIH HHS/United States GR - P30EY001931/EY/NEI NIH HHS/United States GR - P30 EY001730/EY/NEI NIH HHS/United States GR - P30EY001730/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110921 PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (CNGA3 protein, human) RN - 0 (CNGB3 protein, human) RN - 0 (Cyclic Nucleotide-Gated Cation Channels) SB - IM MH - Adolescent MH - Adult MH - Color Perception Tests MH - Color Vision Defects/congenital/genetics/*physiopathology MH - Cyclic Nucleotide-Gated Cation Channels/genetics MH - DNA Mutational Analysis MH - Electroretinography MH - Exons/genetics MH - Female MH - Humans MH - Male MH - Middle Aged MH - Mutation MH - Photic Stimulation MH - Photoreceptor Cells, Vertebrate/*pathology MH - Polymerase Chain Reaction MH - Tomography, Optical Coherence MH - Visual Acuity/physiology MH - Visual Field Tests PMC - PMC3183969 EDAT- 2011/07/23 06:00 MHDA- 2011/12/13 00:00 PMCR- 2012/03/01 CRDT- 2011/07/23 06:00 PHST- 2011/07/23 06:00 [entrez] PHST- 2011/07/23 06:00 [pubmed] PHST- 2011/12/13 00:00 [medline] PHST- 2012/03/01 00:00 [pmc-release] AID - iovs.11-7762 [pii] AID - 11-7762 [pii] AID - 10.1167/iovs.11-7762 [doi] PST - epublish SO - Invest Ophthalmol Vis Sci. 2011 Sep 21;52(10):7298-308. doi: 10.1167/iovs.11-7762.